Meanwhile, the CD8+ T cells and CD4+/CD8+ ratio were significantly related to the inflammation status of COVID-19, while the decrease in CD8+ T cells and B cells and the increase in CD4+/CD8+ ratio were associated with poor efficacy after treatment, indicating that some peripheral lymphocyte subsets could be used as predictors of disease progression and treatment effect. Here, CD8A is linked to COVID-19.